Page last updated: 2024-11-08

6-hydroxy-fad

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

6-hydroxy-FAD : Flavin-adenine dinucleotide (FAD) in which the hydrogen at position 6 of the benzo[g]pteridinedione moiety is substituted by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4369241
CHEBI ID40260
SCHEMBL ID23780928
MeSH IDM0148451

Synonyms (19)

Synonym
6-hydroxy-flavin-adenine dinucleotide
6-hydroxyflavine-adenine dinucleotide
DB02654
6-hydroxy-fad
6-hydroxyflavin-adenine dinucleotide
6-ho-fad
adenosine 5'-(trihydrogen diphosphate) 5'->5'-ester with 6-hydroxyriboflavin
[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2r,3s,4s)-2,3,4-trihydroxy-5-(6-hydroxy-7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)pentyl dihydrogen diphosphate
CHEBI:40260
6-hydroxyriboflavin 5'-(trihydrogen diphosphate) 5'->5'-ester with adenosine
adenosine 5'-(3-{d-ribo-5-[6-hydroxy-7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl]-2,3,4-trihydroxypentyl} dihydrogen diphosphate)
6-oh-fad
6-hydroxy flavin adenine dinucleotide
6-hydroxy-7,8-dimethyl-10-(ribityl-5'-adp)-isoalloxazine
[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2r,3s,4s)-2,3,4-trihydroxy-5-(6-hydroxy-7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)pentyl dihydrogen diphosphate (non-preferred name)
Q41596256
Q27120393
SCHEMBL23780928
PD059898
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs)08

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]